Gregory Richard J.

Executive VP & CSO at ImmunoGen, Inc.

Sold, on record
$642k
Dollars the filings state
Form 4 sales
5
Latest Jan 7, 2019
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
5
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Jan 7, 2019Plan not stated

    ImmunoGen, Inc.

    Sold 1.3% of their holdings

    $16k3,038 shares at $5.27

    Filed Jan 8, 2019Form 4

  2. Feb 22, 2018Plan not stated

    ImmunoGen, Inc.

    Sold 15.5% of their holdings

    $205k36,643 shares at $5.60

    Filed Feb 25, 2019Form 4

  3. Feb 21, 2018Plan not stated

    ImmunoGen, Inc.

    Sold 12.6% of their holdings

    $375k34,486 shares at $10.88

    Filed Feb 23, 2018Form 4

  4. Jan 8, 2017Plan not stated

    ImmunoGen, Inc.

    Sold 1.1% of their holdings

    $19k2,904 shares at $6.64

    Filed Jan 8, 2018Form 4

  5. Jan 8, 2016Plan not stated

    ImmunoGen, Inc.

    Sold 9.5% of their holdings

    $26k2,369 shares at $11.10

    Filed Jan 11, 2016Form 4

5 of 5

Every transaction

Every transaction on a Form 4 or Form 5 by Gregory Richard J.
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jun 15, 2022Jun 17, 2022QTTBDirectorAwardedOption (Right to Buy)18,00018,000SEC
Jun 17, 2021Jun 22, 2021QTTBDirectorAwardedOption (Right to Buy)18,00018,000SEC
Jun 10, 2020Jun 12, 2020QTTBDirectorAwardedOption (Right to Buy)18,00018,000SEC
Nov 18, 2019Jan 29, 2020QTTBDirectorExercised or settledEmployee Stock Option10,8060SEC
Nov 18, 2019Jan 29, 2020QTTBDirectorExercised options10,806$0.0300$32410,806SEC
Jun 6, 2019Jun 10, 2019QTTBDirectorAwardedOption (Right to Buy)15,58015,580SEC
Jan 31, 2019Feb 4, 2019ImmunoGen, Inc.Executive VP & CSOAwardedStock option (right to buy)289,150$5.25$1.5M289,150SEC
Jan 7, 2019Jan 8, 2019ImmunoGen, Inc.Executive VP & CSOSold3,038$5.27$16k236,056SEC
Mar 27, 2018Mar 29, 2018QTTBDirectorAwardedEmployee stock option31,16031,160SEC
Feb 22, 2018Feb 25, 2019ImmunoGen, Inc.Executive VP & CSOSold36,643$5.60$205k199,413SEC
Feb 21, 2018Feb 23, 2018ImmunoGen, Inc.Executive VP & CSOSold34,486$10.88$375k239,094SEC
Feb 15, 2018Feb 20, 2018ImmunoGen, Inc.Executive VP & CSOAwardedStock option (right to buy)256,500$10.65$2.7M256,500SEC
Feb 21, 2017Feb 23, 2017ImmunoGen, Inc.Executive VP & CSOAwarded237,250$2.47$586k276,481SEC
Jan 8, 2017Jan 8, 2018ImmunoGen, Inc.Executive VP & CSOSold2,904$6.64$19k273,577SEC
Nov 2, 2016Nov 3, 2016ImmunoGen, Inc.Executive VP & CSOBought16,600$1.78$30k39,231SEC
Jul 18, 2016Jul 20, 2016ImmunoGen, Inc.Executive VP & CSOAwardedStock option (right to buy)110,000$3.05$336k110,000SEC
Jan 8, 2016Jan 11, 2016ImmunoGen, Inc.Executive VP & CSOSold2,369$11.10$26k22,631SEC
Jul 13, 2015Jul 14, 2015ImmunoGen, Inc.Executive VP & CSOAwardedStock option (right to buy)50,000$16.72$836k50,000SEC

Sales and notices (5)

Form 144 notices and Form 4 sales by Gregory Richard J.
Source
Jan 7, 2019Jan 8, 2019ImmunoGen, Inc.Executive VP & CSOForm 4 sale3,038$16k1.3%Plan not statedSEC
Feb 22, 2018Feb 25, 2019ImmunoGen, Inc.Executive VP & CSOForm 4 sale36,643$205k15.5%Plan not statedSEC
Feb 21, 2018Feb 23, 2018ImmunoGen, Inc.Executive VP & CSOForm 4 sale34,486$375k12.6%Plan not statedSEC
Jan 8, 2017Jan 8, 2018ImmunoGen, Inc.Executive VP & CSOForm 4 sale2,904$19k1.1%Plan not statedSEC
Jan 8, 2016Jan 11, 2016ImmunoGen, Inc.Executive VP & CSOForm 4 sale2,369$26k9.5%Plan not statedSEC